Working Groups
To achieve its objectives, Medi-CaSE is structured into six Working Groups (WGs).
Each WG addresses a specific priority area in the field of cancer secondary prevention, fostering collaboration among researchers, healthcare professionals, policymakers, and stakeholders from across the Mediterranean region.
Each Working Group (WG) within Medi-CaSE is coordinated by a WG Leader and a WG Co-Leader, appointed by the Management Committee (MC) of the Action.
They are responsible for guiding the WG’s activities, facilitating collaboration among members, and ensuring alignment with Medi-CaSE objectives and timelines.
Participation in a Working Group is open to all members of the Action who actively contribute to its goals.Researchers, professionals, and stakeholders interested in joining a WG can express their interest by contacting the WG Leader or Co-Leader, or through their national Management Committee representative.
New members are welcomed on a rolling basis, ensuring a dynamic and inclusive network that values multidisciplinary expertise and geographic balance.
WG1 focuses on strengthening and harmonizing early diagnosis and screening programmes for breast, cervical, and colorectal cancers across Mediterranean countries.Its [...]
WG2 aims to build a shared research platform that fosters cross-border collaboration and innovation in cancer screening.Its objectives include: WG2 [...]
WG3 is dedicated to capacity building and education, ensuring that all professionals involved in cancer prevention possess the skills needed [...]
WG4 works to enhance public awareness and participation in cancer screening programmes.Recognizing the diversity of Mediterranean populations, it places particular [...]
WG5 focuses on embedding cancer prevention and early detection activities into existing health systems.It promotes integration, efficiency, and continuity of [...]
WG6 ensures that Medi-CaSE activities, findings, and achievements are effectively communicated to both the scientific community and the general public.Its [...]